• Illumina named Mike Sullivan chief commercial officer, effective July 20, 2026, to lead its global commercial organization.
• Sullivan was chief commercial officer at Caris Life Sciences; previously held senior commercial roles at Roche Diagnostics, Ortho Clinical Diagnostics, IDEXX, Abbott.
• Julie Coletti was appointed chief legal officer, effective Aug. 3, 2026; she will lead legal and government affairs, serve as corporate secretary.
• Coletti was chief legal and regulatory officer at Align Technology; previously held senior legal leadership roles at Danaher, Bayer HealthCare.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Illumina Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607090905PR_NEWS_USPR_____LA01132) on July 09, 2026, and is solely responsible for the information contained therein.